Prevention of collagen-induced arthritis (CIA) by treatment with polyethylene glycol-conjugated type II collagen; distinct tolerogenic property of the conjugated collagen from the native one.

Source:http://linkedlifedata.com/resource/pubmed/id/9158088

Download in:

View as

General Info

PMID
9158088